ArticleCancers2024

High Mobility Group AT-hook 2: A Biomarker Associated with Resistance to Enzalutamide in Prostate Cancer Cells.

Yusuf Mansur Liadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.